ResearcherLinköping UniversityNo recent work listed

Atul Batra

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1934-8408; OpenAlex author ID A5076311536. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 2 papers

Papers 2

Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. Co-author DOI 10.1097/coc.0000000000000856 ↗
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. First author DOI 10.5306/wjco.v12.i9.787 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Winson Y. Cheung · 2 shared papers, 2021 · strength 0.41
- Paper Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX… DOI 10.1097/coc.0000000000000856 ↗
- Paper Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. DOI 10.5306/wjco.v12.i9.787 ↗
Nils O. Elander · 1 shared paper, 2021 · strength 0.19
- Paper Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. DOI 10.5306/wjco.v12.i9.787 ↗
Hakon Blomstrand · 1 shared paper, 2021 · strength 0.19
- Paper Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. DOI 10.5306/wjco.v12.i9.787 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.